55.7 F
San Diego
Tuesday, Mar 19, 2024
-Advertisement-

Peers, Patients Honor Kaiser Doctors for Work

Peers, Patients Honor Kaiser Doctors for Work

Kaiser Permanente in San Diego recently honored two physicians voted by their peers and health plan members as providing exceptional care.

Dr. Tom Paluch, a surgeon, was named Kaiser’s 2002 Physician of the Year by his peers while Dr. Cathy Steyn, a family practitioner, won the Elisabeth Schilling Award for Compassionate Care from health plan members who were surveyed.

Paluch has been with the department of surgery since 1990.

He is director of Kaiser’s advanced laparoscopic training program and also an assistant clinical professor of surgery at UCSD.

Steyn has been a family practitioner at Kaiser since 1991 after completing her residency at Kaiser’s medical center in Los Angeles.

She went to medical school at the University of Southern California School of Medicine and received her master’s of public health in epidemiology from the UCLA School of Public Health.

Local Biotech Undergoes Major Management Changes

Nanogen Inc. announced major changes in top management.

Kieran Gallahue, who was president of the San Diego-based biotech chip maker for the past 18 months, resigned “to pursue opportunities associated with an unrelated medical technologies firm,” Nanogen said in a Nov. 21 statement.

Bruce Huebner, who has been a Nanogen consultant since August, replaced Gallahue as president and will assume additional responsibilities as COO.

Huebner served in top management positions at another San Diego-based diagnostic maker, Gen-Probe since 1992. He spent nearly three decades in the diagnostic area and held leadership positions at Hybritech, the first biotech company in San Diego, and Roche Diagnostics, a major pharmaceutical firm.

White will step down as CEO and from the firm’s board of directors at year-end for “personal health reasons,” Nanogen said.

Randy White was named CEO in June 2001.

Howard Birndorf, a company founder and current executive chairman will replace White as CEO.

Nanogen stock, which is traded on the Nasdaq stock exchange, closed at $2.05 on Nov. 29.

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-